Literature DB >> 20877181

Patients presenting with severe hypotonic hyponatremia: etiological factors, assessment, and outcomes.

Thuy Vu1, Rosemary Wong, P Shane Hamblin, Jeffrey Zajac, Mathis Grossmann.   

Abstract

BACKGROUND: Although hospital-acquired hyponatremia is well described, severe community-acquired hyponatremia has been studied less extensively. AIM: To assess characteristics and outcomes of patients admitted with severe hypotonic hyponatremia (SHH) (defined as serum sodium ≤ 120 mmol/L).
METHODS: All patients with serum sodium of ≤ 120 mmol/L who were admitted to 2 large teaching hospitals from January 2000 to August 2007 were identified, and data were obtained from medical records. Main outcome measures were incidence of osmotic demyelination and mortality.
RESULTS: Two hundred fifty-five patients were admitted who had SHH (female to male ratio 2:1), and the mean age was 72 ± 14 years. The most common etiological factors were thiazide/indapamide diuretics (41%), syndrome of inappropriate antidiuretic hormone secretion (38%), and hypovolemia (24%). Inappropriately rapid correction of serum sodium (> 12 mmol/L over the first 24 hours) occurred in 37 patients (15%), with 4 patients (11%) developing osmotic demyelination. Patients who developed osmotic demyelination were more likely to be younger, abuse alcohol (3 of 4 patients), and have lower serum potassium levels. One patient had a hypoxic-anoxic episode at presentation. The patients also had a mean serum sodium increase in the first 24 and 48 hours of 21 ± 5 mmol/L and 28 ± 8 mmol/L, respectively. None of the patients with osmotic demyelination received hypertonic saline. None of the patients in whom the serum sodium increment was limited to ≤ 12 mmol/L developed osmotic demyelination. Overall, mortality was 10% and was not related to sodium level at presentation.
CONCLUSIONS: Patients treated with thiazide or indapamide (particularly elderly women) may benefit from monitoring of serum sodium levels. Inappropriately rapid serum sodium correction is associated with osmotic demyelination, particularly in patients with risk factors for this condition. In contrast to what has been reported for hyponatremia in hospitalized patients, severity of hyponatremia on admission did not predict increased mortality in our patient population.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20877181     DOI: 10.3810/hp.2009.12.266

Source DB:  PubMed          Journal:  Hosp Pract (1995)        ISSN: 2154-8331


  13 in total

1.  Mortality and serum sodium: do patients die from or with hyponatremia?

Authors:  Arun Chawla; Richard H Sterns; Sagar U Nigwekar; Joseph D Cappuccio
Journal:  Clin J Am Soc Nephrol       Date:  2011-03-24       Impact factor: 8.237

Review 2.  Treatment of Severe Hyponatremia.

Authors:  Richard H Sterns
Journal:  Clin J Am Soc Nephrol       Date:  2018-01-02       Impact factor: 8.237

3.  Risk Factors and Outcomes of Rapid Correction of Severe Hyponatremia.

Authors:  Jason C George; Waleed Zafar; Ion Dan Bucaloiu; Alex R Chang
Journal:  Clin J Am Soc Nephrol       Date:  2018-06-05       Impact factor: 8.237

4.  Hyponatremia in the outpatient setting: clinical characteristics, risk factors, and outcome.

Authors:  Vildan Tasdemir; Ali Kemal Oguz; Irmak Sayın; Ihsan Ergun
Journal:  Int Urol Nephrol       Date:  2015-10-22       Impact factor: 2.370

5.  Effect of hypokalemia on the clinical impact of hyponatremia.

Authors:  Mohamed Osama Hegazi
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-05-03       Impact factor: 3.738

6.  Prognosis of patients with severe hyponatraemia is related not only to hyponatraemia but also to comorbidities and to medical management: results of an observational retrospective study.

Authors:  Thierry Krummel; Eric Prinz; Marie-Astrid Metten; Claire Borni-Duval; Dorothée Bazin-Kara; Emmanuelle Charlin; Jean-Marc Lessinger; Thierry Hannedouche
Journal:  BMC Nephrol       Date:  2016-10-22       Impact factor: 2.388

7.  A low initial serum sodium level is associated with an increased risk of overcorrection in patients with chronic profound hyponatremia: a retrospective cohort analysis.

Authors:  Sae Aratani; Masahiko Hara; Masahiko Nagahama; Fumika Taki; Miyuki Futatsuyama; Shuichi Tsuruoka; Yasuhiro Komatsu
Journal:  BMC Nephrol       Date:  2017-10-18       Impact factor: 2.388

8.  Investigation and management of moderate to severe inpatient hyponatraemia in an Australian tertiary hospital.

Authors:  Kathryn Berkman; Kate Haigh; Ling Li; Jack Lockett; Goce Dimeski; Anthony Russell; Warrick J Inder
Journal:  BMC Endocr Disord       Date:  2018-12-06       Impact factor: 2.763

9.  Indapamide-induced Severe Hyponatremia in a Middle-aged Male Patient within Two Weeks.

Authors:  Phool Iqbal; Bushra K Laswi; Rashid Kazman; Haajra Fatima; Ali Ait Hssain
Journal:  Cureus       Date:  2019-12-30

Review 10.  Clinical review: practical approach to hyponatraemia and hypernatraemia in critically ill patients.

Authors:  Christian Overgaard-Steensen; Troels Ring
Journal:  Crit Care       Date:  2013-02-27       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.